Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Software Link with Picis

25 Apr 2006 07:00

For immediate release 25 April 2006 LiDCO Group plc Software Link with Picis LiDCO Group plc (AIM: LID), the cardiovascular monitoring company, is pleasedto announce that Picis, the leading provider of high-acuity care automationsoftware for hospitals, is to create a custom device link between LiDCO'sproprietary, stand-alone monitoring system and the Picis CareSuite¢â€ž¢ hospitalinformation management system (HIS) or any other HIS that Picis communicatesto. Once completed, the communications link will allow Picis customers accessto LiDCO's proprietary, minimally-invasive hemodynamic monitoring data. Theintegration of critical care parameters and data derived from the LiDCOplusmonitor will allow a full picture of the patient's condition and history to bedisplayed and accessed throughout the hospital.LiDCO's CEO, Dr. Terry O'Brien, commented: "The communications link willfurther enhance the utility of the LiDCOplus system for both our existing andfuture Picis customers. LiDCO will continue to explore additional non-exclusivecollaborations with the major corporations providing monitoring products to theacute care hospital market. Our ambition is to make LiDCO's technology thestandard of care throughout the hospital for minimally-invasive hemodynamicmonitoring."For further information please contact:LiDCO Group Plc Tel: +44 (0)20 7749 1500 Terry O'Brien - Chief Executive Hugh McGarel-Groves - Finance Director Buchanan Communications Tim Anderson, James Strong Tel: +44 (0)20 7466 5000 Panmure Gordon Grant Harrison, Aubrey Powell, Katherine Roe Tel: +44 (0)20 7459 3600 Notes to EditorsAbout LiDCO PlcLiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier ofminimally invasive, computer-based hemodynamic monitoring equipment anddisposables used primarily for the management of critical care andcardiovascular risk hospital patients. Use of LiDCO's technology has been shownto significantly reduce the complications (particularly infections) and costsassociated with major surgery. The technology was invented in the Department ofApplied Physiology based at St Thomas' Hospital, London where the Companymaintains a research base.The Company's manufacturing facility is in Hoxton, London and its currentproducts are: * LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume; * LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner. Distribution Network:The Company has now achieved registration of its products in 16 markets inEurope, the USA, Brazil and Japan. It sells direct to the NHS in the UK, andthrough a worldwide network of specialty critical care distributors.About PicisPicis is the leading, worldwide provider of information systems that deliverproven best-in-cluster patient care transformation for the highest-acuity careareas of the hospital - the emergency department, the operating room and theintensive care unit. Headquartered in Wakefield, Massachusetts, Picis hasinstalled systems in more than 900 medical centers and hospital networksworldwide including over 700 in North America, automating more surgicalprocedures, emergency visits and intensive care stays than any other company inthe world. Picis has received numerous awards, including those from Microsoft,Ernst & Young, HCIT Research, Healthcare Informatics and Frost and Sullivan.Picis was recently named to both the Deloitte & Touche Fast 500 and the Inc.Magazine 500 lists (105th overall) of the fastest growing private companies inthe U.S. More information is available at www.picis.com.ENDLIDCO GROUP PLC
Date   Source Headline
14th Feb 20181:15 pmRNSHolding(s) in Company
1st Feb 20187:00 amRNSBlock Listing Review
17th Jan 20187:00 amRNSJapan registration &appointment of new distributor
15th Jan 201810:06 amRNSHolding(s) in Company
13th Dec 20174:33 pmRNSHolding(s) in Company
22nd Nov 20179:28 amRNSHolding(s) in Company
10th Oct 20177:00 amRNSHalf-year Report
10th Aug 20177:01 amRNSTrading update & Notice of results
10th Aug 20177:00 amRNSFirst High Usage Programme Account in US
1st Aug 20177:00 amRNSBlock Listing Review
25th Jul 20174:37 pmRNSHolding(s) in Company
6th Jul 20177:00 amRNSConfirmation of CFO appointment & Award of options
8th Jun 20177:00 amRNSInvestor presentation
7th Jun 20177:00 amRNSUS FDA clearance for LiDCOunity v2
10th May 201711:35 amRNSResult of AGM
10th May 20177:00 amRNSAGM Statement
9th May 20177:00 amRNSNew LiDCOunity v2 monitor launch
4th May 20177:00 amRNSLaunch of new website
28th Apr 20177:00 amRNSHolding(s) in Company
20th Apr 20177:00 amRNSAward of share options/ director dealing
3rd Apr 20177:00 amRNSInvestor presentation
3rd Apr 20177:00 amRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSNotice of Results
1st Mar 20177:00 amRNSBoard Changes
16th Feb 201710:07 amRNSHolding(s) in Company
14th Feb 20177:00 amRNSTrading update and notice of results
3rd Feb 20177:00 amRNSHolding(s) in Company
19th Jan 201710:29 amRNSHoldings in Company
18th Jan 20177:00 amRNSHolding(s) in Company
10th Jan 20177:00 amRNSAppointment of Head of North America
3rd Jan 20171:03 pmRNSHolding(s) in Company
3rd Jan 201712:31 pmRNSHolding(s) in Company
3rd Jan 201712:30 pmRNSHolding(s) in Company
23rd Dec 201610:23 amRNSResult of GM, TVR and Transactions by PDMRs
7th Dec 20167:00 amRNSProposed Placing & Notice of General Meeting
11th Oct 20167:00 amRNSHalf-year Report
20th Sep 20167:00 amRNSNotice of Results
8th Sep 20167:00 amRNSFurther clinical support for LiDCOrapid
7th Sep 20163:46 pmRNSHolding(s) in Company
11th Aug 20167:01 amRNSAppointment of Non Executive Director
11th Aug 20167:00 amRNSTrading update and notice of results
1st Jun 20169:17 amRNSHolding(s) in Company
25th May 201612:28 pmRNSResult of AGM
25th May 20167:00 amRNSAGM Statement
16th May 20167:00 amRNSUS Distribution Agreement with ICU Medical
6th May 20167:00 amRNSNotice of AGM
21st Apr 20167:00 amRNSUS launch of new LiDCOunity monitor
4th Apr 20167:00 amRNSUS FDA 510k clearance for LiDCOunity
30th Mar 201611:23 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.